BioSpace.com

WASHINGTON, Aug 31 (Reuters) - U.S. health officials have issued a warning to Baxter International Inc (BAX.N) for misleading patients and doctors about the benefits of its Aralast lung drug.

CASTRES, France, September 1, 2010 /PRNewswire/ -- During its first meeting, the Board of Directors of Pierre Fabre SA chaired by Mr. Pierre Fabre appointed Olivier BOHUON as the company's Chief Executive Officer.

Olivier BOHUON, 51, has until now been the executive vice-president of Abbott Corporation and president of its pharmaceutics division. In this capacity, he directed the group's entire...

WebMD -- Aug. 31, 2010 -- Adding more selenium to your diet may reduce your risk of bladder cancer.

PRINCETON, N.J., Sept. 1 /PRNewswire/ -- Celator Pharmaceuticals, a privately held pharmaceutical company developing new and more effective therapies to treat cancer based on the company's proprietary technology, today announced that it raised $20 million in a Series D private equity...

Reallyworks.org -- When it comes to staying sharp as you age, one body type might just have the edge on the others. A new U.S. study in the July 14, 2010 issue of the Journal of the American Geriatric Society finds that older obese women are more likely to have memory problems if they carry excess hip fat... the so called pear shape.

IRVINE, Calif., Sep 01, 2010 (BUSINESS WIRE) -- Allergan, Inc. /quotes/comstock/13*!agn/quotes/nls/agn (AGN 61.42, -0.59, -0.95%) today announced that it has reached a resolution with the United States Department of Justice (DOJ) regarding the previously reported Government investigation into Allergan's past U.S. sales and marketing practices relating to certain therapeutic uses of BOTOX(R) (onabotulinumtoxinA...

MedPage Today -- STOCKHOLM -- An investigational oral anticoagulant appears to be as effective and safe as treatment with enoxaparin (Lovenox) plus warfarin (Coumadin) to prevent recurrent deep vein thrombosis, researchers reported.

READING, England, September 1, 2010 /PRNewswire/ -- Archimedes Pharma Ltd., a leading international specialty pharma company, today announced that the European Commission has granted marketing authorisation for its lead product, PecFent*, an innovative fentanyl nasal spray for the treatment of breakthrough cancer pain (BTCP) in adults who are already receiving maintenance opioid therapy for chronic...

Pizaazz -- Paying people to avoid sexually transmitted diseases effectively reduces their spread, according to a proof-of-concept study carried out by scientists at UC Berkeley, the Development Research Group at the World Bank and the Ifakara Health Institute in Tanzania.

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE:EBS - News) announced today that it has signed a contract valued at up to $28.7 million with the National Institute of Allergy and Infectious Diseases (NIAID), an institute within the National Institutes of Health (NIH), for advanced development of the companys third generation anthrax vaccine candidate. The award of this contract increases...

LEUVEN, Belgium, September 1, 2010 /PRNewswire-FirstCall/ --

- Data Presented at ASRS Confirm Previous Phase III Findings and Microplasmin's Potential to Transform the Treatment of Retinal Disorders

ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer announces...

ScienceDaily (Aug. 31, 2010) In 2009, a study was conducted in UK by Liverpool John Moores University and the Countess of Chester Hospital to assess the effects of running in ultra-endurance races. Typically aimed at super-fit and experienced athletes, these races are held over distances exceeding 50 miles (80 kilometres).

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE:AGN - News) today announced the United States Food and Drug Administration (FDA) has approved LUMIGAN (bimatoprost ophthalmic solution) 0.01% as a first-line therapy indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. LUMIGAN 0.01% is an optimized reformulation of LUMIGAN...

Blogspot -- The average daily salt intake in America is one and 1/2 teaspoon a day. This is 3,400 milligrams of sodium a day, or 1,100 milligrams more then the recommended maximum.

EurekAlert! -- A study published in the September 2010 issue of SHOCK by Dr. Ed W. Childs and colleagues at Scott & White Healthcare looks at how female versus male rats fared after suffering a trauma and subsequent hemorrhagic shock who were given Estradiol (estrogen). In the study, the Estradiol prevented vascular permeability following hemorrhagic shock.

Medical News Today -- Oesophageal cancer rates in men have risen by 50 per cent over the last 25 years, according to new figures published by Cancer Research UK today.

E Science News -- As anyone who has ever struggled to keep his or her eyes open after a big meal knows, eating can induce sleepiness. New research in fruit flies suggests that, conversely, being hungry may provide a way to stay awake without feeling groggy or mentally challenged. Scientists at Washington University School of Medicine in St. Louis found in a study of fruit flies that starvation allows...

EurekAlert! -- Here's good news for anyone trying to lose weight or has osteoporosis: Scientists from Maine are on the trail of a weight loss drug that may revolutionize how we treat these two conditions. In a new research report published in the September 2010 print issue of The FASEB Journal, the researchers describe a newly discovered protein, called "Sprouty," responsible for regulating body fat...

STOCKHOLM, Aug 31 (Reuters) - An experimental drug from Bristol-Myers Squibb (BMY.N) and Pfizer (PFE.N) reduces the risk of stroke by more than half compared with aspirin, with no significant rise in major bleeding, researchers said on Tuesday.

FRANKFURT, Germany--(BUSINESS WIRE)--DA Prasanna, Founder and Chairman of EA, is pleased to announce the reappointment of Dr Klaus D. Wiedey as Managing Director of EA and CEO Europe. Dr Wiedey succeeds Dr Antal Hajos, reassuming the overall responsibility for business, strategic and operational aspects of the European operations.

As founder and CEO of Ecron in Europe, Dr Wiedey led the company...